• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中葡萄糖脑苷脂酶(GBA)突变的外显率:一项近亲队列研究。

Penetrance of Glucocerebrosidase (GBA) Mutations in Parkinson's Disease: A Kin Cohort Study.

机构信息

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Torino, Italy.

Unit of Medical Statistics and Epidemiology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy, and CPO-Piedmont, Novara, Italy.

出版信息

Mov Disord. 2020 Nov;35(11):2111-2114. doi: 10.1002/mds.28200. Epub 2020 Aug 7.

DOI:10.1002/mds.28200
PMID:32767585
Abstract

BACKGROUND

Homozygous glucocerebrosidase mutations cause Gaucher disease, whereas heterozygous mutations are the most important genetic risk factor for Parkinson's disease (PD). The penetrance of heterozygous glucocerebrosidase mutations for PD is variable (10%-30%), depends on the population studied, and has only been assessed in Gaucher disease or familial PD. The aim of this study was to assess the penetrance of glucocerebrosidase mutations in PD in unselected PD patients.

METHODS

The penetrance of glucocerebrosidase mutations was estimated using the kin-cohort method.

RESULTS

Data on family history were available for 63 of 123 PD glucocerebrosidase mutation carriers, identified among 2843 unrelated consecutive PD patients. Three hundred eighty-one first-degree relatives were analyzed. The risk of developing PD was 10% at 60 years, 16% at 70 years, and 19% at 80 years.

CONCLUSIONS

The estimated penetrance of glucocerebrosidase mutations in unselected PD patients is higher than that estimated in Gaucher disease cohorts and lower than that estimated in familial PD cohorts. © 2020 International Parkinson and Movement Disorder Society.

摘要

背景

纯合葡萄糖脑苷脂酶突变导致戈谢病,而杂合突变是帕金森病(PD)的最重要遗传风险因素。杂合葡萄糖脑苷脂酶突变对 PD 的外显率是可变的(10%-30%),取决于所研究的人群,并且仅在戈谢病或家族性 PD 中进行了评估。本研究旨在评估未选择的 PD 患者中葡萄糖脑苷脂酶突变对 PD 的外显率。

方法

使用亲缘队列法估计葡萄糖脑苷脂酶突变的外显率。

结果

在 2843 例无关的连续 PD 患者中,确定了 123 例 PD 葡萄糖脑苷脂酶突变携带者,其中 63 例有家族史数据。分析了 381 名一级亲属。60 岁时 PD 的发病风险为 10%,70 岁时为 16%,80 岁时为 19%。

结论

在未选择的 PD 患者中,估计葡萄糖脑苷脂酶突变的外显率高于戈谢病队列中的估计值,低于家族性 PD 队列中的估计值。© 2020 国际帕金森病和运动障碍学会。

相似文献

1
Penetrance of Glucocerebrosidase (GBA) Mutations in Parkinson's Disease: A Kin Cohort Study.帕金森病中葡萄糖脑苷脂酶(GBA)突变的外显率:一项近亲队列研究。
Mov Disord. 2020 Nov;35(11):2111-2114. doi: 10.1002/mds.28200. Epub 2020 Aug 7.
2
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers.葡萄糖脑苷脂酶基因突变携带者帕金森病的外显率。
Neurology. 2012 Feb 7;78(6):417-20. doi: 10.1212/WNL.0b013e318245f476. Epub 2012 Jan 25.
3
Decreased Penetrance of Parkinson's Disease in Elderly Carriers of Glucocerebrosidase Gene L444P/R Mutations: A Community-Based 10-Year Longitudinal Study.载脂蛋白 E ε4 等位基因与帕金森病的相关性:一项基于人群的 10 年纵向研究。
Mov Disord. 2020 Apr;35(4):672-678. doi: 10.1002/mds.27971. Epub 2020 Jan 8.
4
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.氨溴索可改善葡萄糖脑苷脂酶突变相关帕金森病细胞的溶酶体生化特性。
Brain. 2014 May;137(Pt 5):1481-95. doi: 10.1093/brain/awu020. Epub 2014 Feb 25.
5
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.伴有和不伴有GBA突变的帕金森病中的葡萄糖脑苷脂酶活性
Brain. 2015 Sep;138(Pt 9):2648-58. doi: 10.1093/brain/awv179. Epub 2015 Jun 27.
6
Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.GBA突变型帕金森病中的葡萄糖脑苷脂酶活性
J Clin Neurosci. 2016 Jun;28:185-6. doi: 10.1016/j.jocn.2015.12.004. Epub 2016 Feb 5.
7
β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.β-葡萄糖脑苷脂酶基因突变在两组希腊散发性帕金森病患者中。
Mol Genet Metab. 2011 Sep-Oct;104(1-2):149-52. doi: 10.1016/j.ymgme.2011.06.015. Epub 2011 Jun 24.
8
Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease.葡萄糖脑苷脂酶携带者伴或不伴帕金森病的细胞因子和 Gaucher 生物标志物。
Mov Disord. 2021 Jun;36(6):1451-1455. doi: 10.1002/mds.28525. Epub 2021 Feb 11.
9
Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.葡萄糖脑苷脂酶突变是帕金森病的主要遗传风险因素,在一个佛兰德 - 比利时队列中会增加患痴呆症的易感性。
Neurosci Lett. 2016 Aug 26;629:160-164. doi: 10.1016/j.neulet.2016.07.008. Epub 2016 Jul 7.
10
Blood lysosphingolipids accumulation in patients with parkinson's disease with glucocerebrosidase 1 mutations.帕金森病伴葡萄糖脑苷脂酶 1 突变患者血液溶血磷脂酰胆碱的积累。
Mov Disord. 2018 Aug;33(8):1325-1330. doi: 10.1002/mds.27393. Epub 2018 Sep 7.

引用本文的文献

1
Penetrance of Parkinson's disease in GBA1 carriers depends on variant severity and polygenic background.GBA1基因携带者中帕金森病的外显率取决于变异的严重程度和多基因背景。
NPJ Parkinsons Dis. 2025 Jun 12;11(1):162. doi: 10.1038/s41531-025-00997-y.
2
Genetic Sketch of Parkinson's Disease in India.印度帕金森病的基因概述。
Ann Indian Acad Neurol. 2025 Jul 1;28(4):495-504. doi: 10.4103/aian.aian_1021_24. Epub 2025 May 7.
3
Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease.分阶段筛查可识别出与神经元α-突触核蛋白病相关生物标志物的人群。
Ann Neurol. 2025 Apr;97(4):730-740. doi: 10.1002/ana.27158. Epub 2024 Dec 24.
4
Mitochondrial oxidant stress promotes α-synuclein aggregation and spreading in mice with mutated glucocerebrosidase.线粒体氧化应激促进葡糖脑苷脂酶突变小鼠中α-突触核蛋白的聚集和扩散。
NPJ Parkinsons Dis. 2024 Dec 11;10(1):233. doi: 10.1038/s41531-024-00842-8.
5
Sex Differences in Parkinson's Disease: A Narrative Review.帕金森病中的性别差异:一项叙述性综述。
Neurol Ther. 2025 Feb;14(1):57-70. doi: 10.1007/s40120-024-00687-6. Epub 2024 Dec 4.
6
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson's disease.GBA1 相关帕金森病的临床、机制、生物标志物和治疗进展。
Transl Neurodegener. 2024 Sep 12;13(1):48. doi: 10.1186/s40035-024-00437-6.
7
Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson's Disease.GBA1基因变异的遗传咨询共识指南:聚焦帕金森病
Mov Disord. 2024 Dec;39(12):2144-2154. doi: 10.1002/mds.30006. Epub 2024 Sep 11.
8
Gaucher disease provides a unique window into Parkinson disease pathogenesis.戈谢病为帕金森病发病机制的研究提供了一个独特的窗口。
Nat Rev Neurol. 2024 Sep;20(9):526-540. doi: 10.1038/s41582-024-00999-z. Epub 2024 Aug 6.
9
-Associated Parkinson's Disease Is a Distinct Entity.与帕金森病相关联的疾病是一个独特的实体。
Int J Mol Sci. 2024 Jun 28;25(13):7102. doi: 10.3390/ijms25137102.
10
Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson's Disease: A Narrative Review.识别帕金森病前驱期/早期个体的伦理考虑:叙事综述。
J Parkinsons Dis. 2024;14(s2):S307-S319. doi: 10.3233/JPD-230428.